Beta Drugs Limited — Board Meeting, 03-09-2026: Outcome of Board Meeting

Beta Drugs' board approved its FY26 Director's Report and set the AGM for Sept 30, 2026. M/s Khurana Sharma & Co was re-appointed as Statutory Auditor. Whole-Time Director Ashutosh Shukla's 5-year re-appointment with revised pay received board approval, pending shareholder nod.